Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Taxes (2016 - 2020)

Historic Change in Taxes for China Pharma Holdings (CPHI) over the last 12 years, with Q3 2020 value amounting to -$155827.0.

  • China Pharma Holdings' Change in Taxes fell 33274.09% to -$155827.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $113571.0, marking a year-over-year increase of 131518.3%. This contributed to the annual value of $12971.0 for FY2019, which is 10881.79% up from last year.
  • According to the latest figures from Q3 2020, China Pharma Holdings' Change in Taxes is -$155827.0, which was down 33274.09% from $227245.0 recorded in Q2 2020.
  • China Pharma Holdings' Change in Taxes' 5-year high stood at $227245.0 during Q2 2020, with a 5-year trough of -$163335.0 in Q1 2018.
  • Moreover, its 5-year median value for Change in Taxes was -$10350.0 (2019), whereas its average is $4244.9.
  • In the last 5 years, China Pharma Holdings' Change in Taxes plummeted by 71117.7% in 2017 and then surged by 265548.68% in 2020.
  • China Pharma Holdings' Change in Taxes (Quarter) stood at $146187.0 in 2016, then crashed by 88.35% to $17034.0 in 2017, then plummeted by 291.78% to -$32667.0 in 2018, then surged by 68.32% to -$10350.0 in 2019, then plummeted by 1405.57% to -$155827.0 in 2020.
  • Its Change in Taxes stands at -$155827.0 for Q3 2020, versus $227245.0 for Q2 2020 and $52503.0 for Q1 2020.